96740 ⎘
Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids
DISEASE INHIBITING AGENT
#3302Treatments of gastrointestinal disorders
#3303FOXM1 peptide and medicinal agent comprising the same
#3304LINACLOTIDE COMPOSITIONS
#3305Peptide library production method, peptide library, and screening method
#3306Stitched polypeptides
#3307Monoclonal antibody having immunosuppressive activity or antigen binding fragment thereof
#3308Natriuretic polypeptides
#3309Beta-catenin targeting peptides and uses thereof
#3310COMPOSITIONS AND METHODS FOR TREATING AIDS OR CANCER BY INHIBITING THE SECRETION OF MICROPARTICLES
#3311MIA (Melanoma Inhibitory Activity) Inhibitors for Detecting, Preventing and Curing Vitiligo
#3312Methods of reducing basophil levels
#3313Methods and compositions for targeting sites of neovascular growth
#3314Method of producing a positive inotropic effect using an antibody that binds sodium potassium atpase
#3315NPR-B agonists
#3316Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method
#3317Method for regulating circadian rhythms
#3318Polypeptides derived from calcitonin receptors and methods of use
#3319Peptide-phospholipid conjugates
#3320Factor H binding peptides and uses thereof
#3321Peptides having antimicrobial activity
#3322Peptides having antimicrobial activity
#3323α-Conotoxin peptides
#3324Methods and compositions for the treatment of axonal and neuronal degeneration
#3325Methods and Compositions for the Treatment of Gastrointestinal Disorders
#3326Use of ide as a biomarker for a scalp condition
#3327Drug transporter permeating blood-brain barrier, peptide and use thereof
#3328BIOMIMETIC PEPTIDES FOR BONE AUGMENTATION
#3329Peptide scaffold design
#3330Anti-ageing peptides modulating survivin and compositions including same
#3331PAR1 and PAR2 c-tail peptides and peptide mimetics
#3332Nitrated cardiac troponin I as a biomarker of cardiac ischemia
#3333COSMETIC USE OF DERMICIDIN, AND ANALOGUES OR FRAGMENTS THEREOF
#3334Powerful MHC-class II peptides derived from survivin
#3335Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof
#3336SYNTHETIC PEPTIDES FOR USE AS INHIBITORS OF NEUROTRANSMITTER SECRETION AND AS INDUCERS OF CELLULAR RELAXATION
#3337NUCLEIC ACIDS ENCODING PEPTIDES FOR TREATING WOUNDS, ANTI-ANGIOGENIC COMPOUNDS AND USES THEREOF
#3338Antioxidant, anti-inflammatory, anti-radiation, metal chelating compounds and uses thereof
#3339PEPTIDES AND RELATED MOLECULES THAT MODULATE NERVE GROWTH FACTOR ACTIVITY
#3340Cross Protective Epitopes of Aspergillus Fumigatus and Candida Albicans
#3341Polypeptides, nucleic acid molecule encoding polypeptides, and uses of polypeptides
#3342Human lactoferrin derived peptides and their use
#3343Glycogen synthase kinase-3 inhibitors
#3344Polypeptides for microbial detection
#3345Affinity peptides toward infliximab
#3346Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#3347USP2A PEPTIDES AND ANTIBODIES
#3348Peptide analogs of alpha-melanocyte stimulating hormone
#3349Glycogen synthase kinase-3 inhibitors
#3350CHIMERIC PEPTIDES INCLUDING A PENETRATING PEPTIDE AND A BINDING DOMAIN OF PP2A CATALYTIC SUBUNIT TO CASPASE-9
#3351Immunomodulatory Compositions, Methods and Systems Comprising Immunogenic Fragments of ApoB-100
#3352Intestinal peptide targeting ligands
#3353Antimicrobial cationic peptides and formulations thereof
#3354METHOD FOR TREATMENT OF INFLAMMATORY DISEASE AND DISORDER
#3355Vaccine comprising Amb a 1 peptides for use in the treatment of ragweed allergy
#3356TARGETING SENESCENT AND CANCER CELLS FOR SELECTIVE KILLING BY INTERFERENCE WITH FOXO4
#3357Dermatopontin-activating peptides and cosmetic compositions including same
#3358Method for ameliorating pain by modification of NMDA receptors through inhibition of SRC
#3359Anticancer fusion protein comprising trail and a growth factor receptor inhibitor
#3360Methods for treating steatotic disease
#3361Immunogenic polypeptides comprising a modified loop peptide presenting the HIV-1 GP120 3074 mAb epitope and scaffold proteins containing said peptide
#3362Detection of degradative enzymes and biomolecules in bodily fluids
#3363High purity lipopeptides
#3364SHORT AND D-AMINO ACID-CONTAINING POLYPEPTIDES FOR THERAPEUTIC CONJUGATES AND USES THEREOF
#3365Compositions and methods for promoting wound healing and tissue regeneration
#3366Peptidomimetic macrocycles
#3367Agonists of Guanylate Cyclase Useful for the Treatment of Gastrointestinal Disorders, Inflammation, Cancer and Other Disorders
#3368Peptides for treating cancer
#3369Selective anticancer chimeric peptides which bind neuropilin receptor
#3370Selective anticancer chimeric peptides which bind transferrin receptor
#3371TFPI inhibitors and methods of use
#3372Peptides and methods of using same
#3373Obesity-related genes and their proteins and uses thereof
#3374Active cores of peptide triazole HIV-1 entry inhibitors
#3375Mammalian colostrum derived nanopeptides for broadspectrum viral and recurrent infections with a method of isolation thereof
#3376Synthetic peptide inhibitors of Wnt pathway
#3377Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and an assay kit
#3378Method for activating helper T cell
#3379SOX9 INHIBITORS
#3380Small cationic antimicrobial peptides
#3381Companion animal treatments
#3382Moesin modulators and uses thereof
#3383USE OF A PHOSPHOPEPTIDE ABLE TO BLOCK HER3/P85 INTERACTION FOR THE TREATMENT OF HER2 HYPER-EXPRESSING TUMOURS
#3384PEPTIDES
#3385CLASS I MHC PHOSPHOPEPTIDES FOR CANCER IMMUNOTHERAPY AND DIAGNOSIS
#3386TFPI inhibitors and methods of use
#3387PLIF multimeric peptides and uses thereof
#3388TFPI inhibitors and methods of use
#3389Peptides of syndecan-1 for inhibit angiogenesis
#3390Therapeutically active α-MSH analogues
#3391BONE MARROW APLASIA WITH HAEMORRHAGIC DISEASE IN CALVES CAUSED BY NOVEL PATHOGEN
#3392Anticancer agents comprising peptides with cancer-specific toxicity
#3393Methods and compositions related to improving properties of pharmacological agents targeting nervous system
#3394Compositions for treatment of neurodegenerative diseases
#3395NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR
#3396VIP fragments and methods of use
#3397Antimicrobial peptides and derived metapeptides
#3398HIGH-EFFICIENCY CATALYSTS, PREPARATION AND USE THEREOF
#3399Method for manufacturing a gold core/insulator shell nanostructure using a novel peptide
#3400Peptide sequences and compositions
#3401Polypeptides with affinity for heat shock proteins (HSPS) and HSP associated complexes (HACS) and their use in diagnosis and therapy
#3402Immunoglobulin cleavage fragments and disease indicators and compositions for detecting and binding such
#3403Cell-permeable peptide
#3404Immunomodulatory methods and systems for treatment and/or prevention of aneurysms
#3405TDF-related compounds and analogs thereof, analogs and bioactive fragments
#3406Synthetic analogues of neural regeneration peptides
#3407Methods for selective targeting
#3408Peptide for use as a medicament, in particular for the treatment of cancer
#3409Immunomodulatory methods and systems for treatment and/or prevention of hypertension
#3410Antidiabetic compounds
#3411Antimicrobial peptides
#3412Peptides based on the transmembrane domain of a toll-like receptor (TLR) for treatment of TLR-mediated diseases
#3413REAGENTS AND METHODS FOR DETECTING PROTEIN CROTONYLATION
#3414Cancer therapy method
#3415ESTROGEN RECEPTOR ALPHA POLYPEPTIDE SEQUENCE, DIAGNOSTIC AND THERAPEUTIC APPLICATIONS THEREOF
#3416Peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity
#3417BCL-G POLYPEPTIDES, ENCODING NUCLEIC ACIDS AND METHODS OF USE
#3418Compositions and methods for modulating γ-c-cytokine activity
#3419ErbB interface peptidomimetics and methods of use thereof
#3420PEPTIDES ABLE TO INTERFERE WITH THE INHIBITING ACTIVITY OF MDM2/MDM4 HETERODIMER TOWARDS P53 AND USE THEREOF FOR CANCER TREATMENT
#3421Dpy-30 binding peptides
#3422Peptide II
#3423Kits for detecting breast or ovarian cancer in a body fluid sample and use thereof
#3424Avian group D rotavirus
#3425Immunotoxin fusion proteins and means for expression thereof
#3426Polypeptide TF1 for inhibiting type 2 Shiga toxin activity, encoding gene for same and use thereof
#3427PEPTIDES, CONSTRUCTS AND USES THEREFOR
#3428METHOD AND PEPTIDE FOR REGULATING CELLULAR ACTIVITY
#3429Immunoregulatory peptides and methods of use
#3430CXCR4 receptor compounds
#3431IL-13 receptor binding peptides
#3432ANTI-VIRAL AGENT
#3433PROTEASE TARGETING AGENTS
#3434Immunoregulatory peptides and methods of use
#3435Immunoregulatory peptides and methods of use
#3436Inhibitors of TLR signaling by targeting TIR domain interfaces
#3437Promiscuous PAP CD4 T cell epitopes
#3438MAMMALIAN GENES; RELATED REAGENTS
#3439Dengue Virus (DV) Polypeptide Sequences, T Cell Epitopes and Methods and Uses Thereof
#3440Compositions and methods useful in enhancement of memory
#3441BNIP3 ISOFORMS AND METHODS OF USE
#3442Synthetic apelin mimetics for the treatment of heart failure
#3443Composite antigenic sequences and vaccines
#3444Antibody targeting through a modular recognition domain
#3445Methods of using halogenated peptides as internal standards for liquid chromatography-mass spectrometry
#3446TUMOR GROWTH CONTROLLING METHOD TARGETING GALACTOSYLCERAMIDE EXPRESSION FACTOR-1
#3447Treatments for Gastrointestinal Disorders
#3448Peptides, derivatives and analogs thereof, and methods of using same
#3449Antiviral peptides against influenza virus
#3450ANTI-HEPARAN SULFATE PEPTIDES THAT BLOCK HERPES SIMPLEX VIRUS INFECTION IN VIVO
#3451COLON AND PANCREAS CANCER SPECIFIC ANTIGENS AND ANTIBODIES
#3452Kinase inhibitors and uses thereof
#3453TREATMENT OF ABNORMAL OR EXCESSIVE SCARS
#3454Extract and peptides derived from Japonica Group and uses thereof
#3455Peptide having a vascularization-suppressing activity and a use therefor
#3456Peptide Inhibitors and Methods of Use Thereof
#3457Thrombin inhibitor
#3458DIHYDROXYPROPLY-CYSTEINE PEPTIDE AND AGENT CONTAINING THIS PEPTIDE
#3459NOVEL C3C EPITOPE, ANTIBODIES BINDING THERETO, AND USE THEREOF
#3460JNK inhibitor molecules
#3461Polypeptides that bound to IL-23 receptor and inhibit binding of IL-23 and cell signaling thereof
#3462Methods and Compositions for Inhibiting Tumor Cell Proliferation
#3463Angiogenesis-inhibiting peptide and application thereof
#3464Growth hormone secretatogue receptor antagonists and uses thereof
#3465Composition for treating sepsis or septic shock comprising the peptide originated from the Smad6
#3466Neurotoxic target for amylospheroid, method and material for reducing the neurotoxicity of amylospheroid, and use thereof
#3467Bispecific T-cell activator antibody
#3468Antimicrobial agent, bacterial strain, biosynthesis, and methods of use
#3469Anticancer fusion protein comprising trail
#3470Lytic-peptide-Her2/neu (human epidermal growth factor receptor 2) ligand conjugates and methods of use
#3471Novel Peptides for Wound Healing
#3472Modulation of ghrelin levels and ghrelin/unacylated ghrelin ratio using unacylated ghrelin
#3473Nociceptin mimetics
#3474RHAMM binding peptides
#3475ISOLATION OF MESENCHYMAL STEM CELLS
#3476Synthetic stereoisomer peptides in the retro-inverso and inverso configuration, and with cyclic and linear structure, their polymer conjugates, their encapsulation in polymer particles, and uses thereof
#3477Parstatin peptides
#3478Therapeutic agents for reducing parathyroid hormone levels
#3479Na+/K+-ATPase-specific peptide inhibitors/activators of Src and Src family kinases
#3480TREATMENT OF VIRAL INFECTIONS
#3481Peptide antimicrobials
#3482Polypeptides for the treatment or prevention of cancer and uses thereof
#3483Mutant human and simian immunodeficiency virus ENV proteins with reduced immunosuppressive properties
#3484αvβ6 peptide ligands and their uses
#3485AGENTS FOR TREATING ALZHEIMER'S DISEASE
#3486Peptides as active agents to stabilize biological barriers
#3487Cancer-targeting peptides and uses thereof in cancer treatment and diagnosis
#3488Akt activity specifically inhibiting polypeptide
#3489Newly identified colon cancer marker and diagnostic kit using the same
#3490Tumor Marker and Methods of Use Thereof
#3491PEPTIDE HAVING CELL MEMBRANE PENETRATING ACTIVITY
#3492Peptide derivatives for biofunctionalization of silicon substrates and their applications
#3493EEF2K assays for identifying compounds that inhibit EEF2K activity
#3494Treatments for gastrointestinal disorders
#3495Antimicrobial peptides and peptide derivatives derived from
#3496eIF4E binding peptides
#3497Compositions for inhibiting immune complex formation in a subject
#3498Methods of treating autoimmune diseases of the central nervous system (CNS) and neurodegenerative diseases
#3499Lactadherin-derived peptides as antiviral agents
#3500Epitopes of the human PDGF receptor able to bind human auto-antibodies, antibodies and uses thereof
#3501Monoclonal antibodies to human immunodeficiency virus and uses thereof
#3502Compositions and methods to detect various infectious organisms
#3503Telomerase polypeptide vaccine for treating cancer
#3504Prevention and treatment of cast nephropathy
#3505SIMULTANEOUS SYNTHESIS OF TEMPERATURE-TUNABLE PEPTIDE AND GOLD NANOPARTICLE HYBRID SPHERES
#3506PEPTIDE FOR IMPROVING BIOSTABILITY OF BIOACTIVE SUBSTANCE, AND BIOACTIVE SUBSTANCE HAVING IMPROVED BIOSTABILITY
#3507Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
#3508PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE
#3509Identification of compounds modifying a cellular response
#3510Signal peptide, and use thereof for producing recombinant proteins
#3511S. EPIDERMIDIS ANTIGENS
#3512BORRELIA ANTIGENS
#3513TARGETED NON-INVASIVE IMAGING PROBES OF EGFR EXPRESSING CELLS
#3514RFamide-Related Peptides and Methods Thereof
#3515Pea protein peptides with anti activity
#3516Peptide domains that bind small molecules of industrial significance
#3517METHODS FOR TREATING OR PREVENTING VASCULAR GRAFT FAILURE
#3518GM1-like peptides and uses thereof
#3519High salt-resistance antibacterial peptide and method for producing the same
#3520Peptide-based inhibitor of interleukin-10 or interferon-gamma signaling
#3521USP2a peptides and antibodies
#3522Wound healing peptides and methods of use thereof
#3523Antibacterial and antifungal peptides
#3524Ezrin assay method for the in vitro diagnosis of colorectal cancer
#3525Methods for selective targeting
#3526Compounds and their use
#3527INHIBITORS OF PROTEIN KINASES AND USES THEREOF
#3528LINEAR IGE PEPTIDE EPITOPES OF HAZELNUT ALLERGEN COR A 1 AND CELERY ANTIGEN API 1
#3529Bone morphogenic protein binding peptide
#3530Peptides or Antibodies Which Bind to Melanoma Inhibitory Activity (MIA) Protein
#3531Hyaluronic acid decomposition-promoting factor and inhibitor thereof
#3532Recombinant human NaGlu protein and uses thereof
#3533Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors
#3534Binding partners of antibodies specific for dendritic cell antigens
#3535Treatments for Gastrointestinal Disorders
#3536PHENOLIC BINDING PEPTIDES
#3537Peptides shared among lethal cancers and therapeutic compositions comprising said peptides
#3538Method for prepairing peptide inhibitors of a lipid-activated enzyme and peptides produced by same
#3539IgA-binding peptide and purification of IgA using the same
#3540Embedded chimeric peptide nucleic acids and uses thereof
#3541Secreted protein acidic and rich in cysteine (SPARC) protein SRM assay
#3542Biosynthetic proline/alanine random coil polypeptides and their uses
#3543Peptides, conjugates and method for increasing immunogenicity of a vaccine
#3544Peptides mimicking HIV-1 viral epitopes in the V2 loop for the GP120 surface envelope glycoprotein
#3545Small heat shock proteins and active fragments thereof as a therapy for inflammation and ischemia
#3546Method and peptide for regulating cellular activity
#3547Methods for detection of botulinum neurotoxin
#3548Amphiphilic peptides and peptide particles
#3549Peptide tag systems that spontaneously form an irreversible link to protein partners via isopeptide bonds
#3550Polypeptide expressed in the stratum corneum and thereof
#3551Self-assembling peptides and their use in the formation of hydrogels
#3552Inhibitors of mitochondrial fission and methods of use thereof
#3553PROTEIN DRUG FORMULATIONS AND PACKAGES
#3554Pro-angiogenic fragments of prominin-1 and uses thereof
#3555Method of selecting polypeptide sequence, and metal oxide or silicon-containing compound binding peptide and use thereof
#3556Mass spectrometric assays for peptides
#3557Inorganic-binding peptides and quality control methods using them
#3558PARENTERAL FORMULATIONS OF PEPTIDES FOR THE TREATMENT OF SYSTEMATIC LUPUS ERYTHEMATOSUS
#3559Oligopeptide compounds and uses thereof
#3560Light-sensitive ion-passing molecules
#3561Compositions and methods for treating aids or cancer by inhibiting the secretion of microparticles
#3562Compositions and methods for treating cancer by inhibiting the secretion of microparticles
#3563Compositions and methods for transport across the blood brain barrier
#3564HAIR-BINDING PEPTIDES
#3565Materials related to sodium/potassium adenosine triphosphatase and Src
#3566ARTIFICIAL PEPTIDE AND USE THEREOF
#3567Composition of tumor-associated peptides and related anti-cancer vaccine for the treatment of glioblastoma (GBM) and other cancers
#3568Joint-homing peptides and uses thereof
#3569Compositions and methods for modulating γ-c-cytokine activity
#3570PROCESS FOR PREPARING CASEIN-DERIVED PEPTIDES BY FERMENTATION OF LACTIC ACID BACTERIA
#3571POTENT D-PEPTIDE ANTAGONISTS OF MDM2 AND MDMX FOR ANTICANCER THERAPY
#3572METHODS FOR DETECTION OF BOTULINUM NEUROTOXIN
#3573Oligopeptide improving differentiation of osteoblasts
#3574Therapeutic use of peptide inhibitors of NADPH oxidase; aerosolization as a delivery mechanism
#3575Peptide inhibiting differentiation of hematopoietic stem cells or hematopoietic precursor cells and use of same
#3576CRYSTALLINE FORM OF LINACLOTIDE
#3577Lantibiotic Salts
#3578Antimicrobial peptides
#3579Actagardine derivatives, and pharmaceutical use thereof
#3580Selective poly-substituted glycine antibiotics and related compositions
#3581NOVEL ANTIMICROBIAL AGENTS
#3582Materials and methods related to sodium/potassium adenosine triphosphase and cholesterol
#3583Method of inhibiting bile acid absorption by administering an agonist of a guanylate cyclase receptor
#3584Treatment of influenza virus infection
#3585Multivalent Antibodies
#3586ATTACHMENT OF BIOLOGICAL TARGETING GROUPS USING METAL FREE CLICK CHEMISTRY
#3587β-hairpin peptidomimetics
#3588Inhibitors of atypical protein kinase C and their use in treating hedgehog pathway-dependent cancers
#3589Template-fixed peptidomimetics with CCR10 antagonistic activity
#3590CONOTOXIN PEPTIDES USEFUL AS INHIBITORS OF NEURONAL AMINE TRANSPORTERS
#3591Composition for improving brain function and method for improving brain function
#3592S. epidermidis antigens
#3593NEUROTROPHINS AND USES THEREOF
#3594Self-assembling peptide amphiphiles and related methods for growth factor delivery
#3595Peptides for the treatment of hearing
#3596Peptides and aptamers thereof as specific modulators of mutant p53 function
#3597DIARYLSULFIDE BACKBONE CONTAINING PHOTOLABILE PROTECTING GROUPS
#3598THROMBOPOIETIC COMPOUNDS
#3599Inhibitors of antigen presentation by MHC class II molecules
#3600Peptide aptamer for neutralizing the binding of platelet antigen specific antibodies and diagnostic and therapeutic applications containing the same